Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study
University of Colorado Denver · Seoul National University · +11 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,275
total citations
- FWCI
- 122.95
- Percentile
- 100%
- References
- 49
Citations per year
Authors
24Topics & keywords
Topics
Keywords
- Crizotinib
- Medicine
- Tolerability
- Internal medicine
- Lung cancer
- Oncology
- Population
- Phases of clinical research
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.